Analysis of bilastine efficacy against chronic cough in patients with allergic rhinitis or atopic dermatitis.

Analysis of bilastine efficacy against chronic cough in patients with allergic rhinitis or atopic dermatitis. - Analysis of bilastine efficacy against allergic cough.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033824

Enrollment

Registered

2018-09-15

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic cough

Interventions

hisatmine H1 receptor antagonist:bilastine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)chronic non-productive cough 2)absence of wheeze and dyspnea 3)resistant to bronchodilator therapy 4)past history and/or complication of allergic rhinitis or atopic dermatitis 5)no medication that causes cough (ACE inhibitor, etc.) 6)over 20 years old 7)written consent form

Exclusion criteria

Exclusion criteria: 1)abnormal findings of chest X-ray 2)patients judged inappropriate by physician

Design outcomes

Primary

Measure	Time frame
Japan-Leicester Cough Questionnaire	—

Secondary

Measure	Time frame
cough severity visual analogue scale and adverse effect.	—

Countries

Japan

Contacts

Public ContactYuichiro Yasuda

Kobe University Graduate School of Medicine Division of Respiratory Medicine, Department of Internal Medicine

yyasuda@med.kobe-u.ac.jp0783825660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026